HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CLMT

Calumet, Inc. (NASDAQ)

Basic Materials — Specialty Chemicals

Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments. The Specialty Products and Solutions segment manufactures and markets various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The Montana/Renewables segment processes geographically advantaged renewable feedstocks into renewable diesel, aviation fuel, and renewable naphtha. This segment also engages in the process of Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. It serves wholesale distributors and retail chains. Calumet, Inc. was founded in 1919 and is headquartered in Indianapolis, Indiana.

Buy 2.3 / 5 5 analysts
$36.43
+$0.41 (+1.14%)
Target: $38.80 (6.5%)
Sign in to add CLMT to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$3.17B
P/E Ratio (TTM)-
Forward P/E117.52
EPS (TTM)$-2.16
Dividend Yield-
Profit Margin-4.52%
Revenue Growth3.60%
ROE-
Debt/Equity-
Recommendation Buy 2.3
Analyst Target$38.80
Analysts5
Indexes NASDAQ

Technical Indicators

RSI (14)60.7
Beta0.72
SMA 20-
SMA 40-
52-Week High$38.75
52-Week Low$12.94
50-Day Avg$33.70
200-Day Avg$25.77
Avg Volume947.6K
Volume840.7K

Performance Analysis

BULLISH

CLMT shows predominantly bullish signals based on its fundamentals and technicals.

- Trading near its 52-week high ($38.75), which may indicate limited upside.
+ RSI at 60.7 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 3.6% year-over-year.
- Operating at a loss with -4.5% margin.
+ Wall Street consensus is "Buy" from 5 analysts.
+ Average analyst target of $38.80 implies 6.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:03 UTC

Back to Screener Export Report